Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology

Trends in Cardiovascular Medicine

Volumn 10, Issue 1, 2000, Pages 19-22

  Han, Jiahuai ^a   Molkentin, Jeffery D ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMEGALY; DNA-BINDING PROTEINS; HEART; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; MYOGENIC REGULATORY FACTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0034528548     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(00)00039-6     Document Type: Review

References (42)

1. Alterations in calcium handling in cardiac hypertrophy and heart failure
2. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion
3. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy
4. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine; a role in cardiac myocyte hypertrophy?
5. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease
6. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis
7. Signaling pathways mediating the response to hypertrophic stress in the heart
8. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
9. Regulatory role of MEF2D in serum induction of the c-jun promoter
10. Cell density and contraction regulate p38 MAP kinase-dependent responses in neonatal rat cardiac myocytes
11. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C
12. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium
13. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C
14. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
15. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
16. Neuronal activity-dependent cell survival mediated by transcription factor MEF2
17. Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons
18. 2-terminal kinase, p38s, and extracellular signal-regulated kinase 5
19. HDAC4 deacetylase associates with and represses the MEF2 transcription factor
20. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins
21. Myocyte-specific enhancer-binding factor (MEF-2) regulates α-cardiac myosin heavy chain gene expression in vitro and in vivo
22. Combinatorial control of muscle development by basic helix-loop-helix and MADs-box transcription factors
23. Calcineurin-dependent transcriptional pathway for cardiac hypertrophy
24. Role of p38 MAP kinase in myocardial stress
25. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy
26. The p38 MAP kinase pathway and its biological function
27. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors
28. The p38 signal transduction pathway; activation and function
29. Post-translational control of the MEF2A transcriptional regulatory protein
30. Human SRF-related proteins; DNA-binding properties and potential regulatory targets
31. The MADS-box family of transcription factors
32. MEF-2 function is modified by a novel co-repressor, MITR
33. 'Stress-responsive' mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium
34. Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at level of translation
35. HDAC, a human histone deacetylase related to yeast HDA1, is a transcriptional co-repressor
36. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
37. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors
38. +-induced release of the transcription factor MEF2
39. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner
40. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression
41. P38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation
42. Regulation of the MEF2 family of transcription factors by p38